- Home
- AUTL vs CCRN Comparison
AUTL vs CCRN Comparison
Compare AUTL & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- CCRN
- Stock Information
- Founded
- AUTL 2014
- CCRN 1986
- Country
- AUTL United Kingdom
- CCRN United States
- Employees
- AUTL N/A
- CCRN N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- CCRN Professional Services
- Sector
- AUTL Health Care
- CCRN Consumer Discretionary
- Exchange
- AUTL Nasdaq
- CCRN Nasdaq
- Market Cap
- AUTL 590.8M
- CCRN 587.1M
- IPO Year
- AUTL 2018
- CCRN N/A
- Fundamental
- Price
- AUTL $2.17
- CCRN $18.19
- Analyst Decision
- AUTL Strong Buy
- CCRN Buy
- Analyst Count
- AUTL 3
- CCRN 3
- Target Price
- AUTL $10.20
- CCRN $18.31
- AVG Volume (30 Days)
- AUTL 1.1M
- CCRN 431.7K
- Earning Date
- AUTL 03-13-2025
- CCRN 02-19-2025
- Dividend Yield
- AUTL N/A
- CCRN N/A
- EPS Growth
- AUTL N/A
- CCRN N/A
- EPS
- AUTL N/A
- CCRN N/A
- Revenue
- AUTL $10,091,000.00
- CCRN $1,448,099,000.00
- Revenue This Year
- AUTL $851.83
- CCRN N/A
- Revenue Next Year
- AUTL $224.65
- CCRN N/A
- P/E Ratio
- AUTL N/A
- CCRN N/A
- Revenue Growth
- AUTL 82.71
- CCRN N/A
- 52 Week Low
- AUTL $2.07
- CCRN $9.58
- 52 Week High
- AUTL $7.37
- CCRN $21.41
- Technical
- Relative Strength Index (RSI)
- AUTL 41.81
- CCRN 71.82
- Support Level
- AUTL $2.11
- CCRN $18.17
- Resistance Level
- AUTL $2.26
- CCRN $18.26
- Average True Range (ATR)
- AUTL 0.12
- CCRN 0.06
- MACD
- AUTL 0.01
- CCRN -0.13
- Stochastic Oscillator
- AUTL 27.78
- CCRN 50.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.